RISC RNA sequencing for context-specific identification of in vivo microRNA targets.

Authors:
Scot J Matkovich
Scot J Matkovich
Center for Pharmacogenomics
William H Eschenbacher
William H Eschenbacher
Washington University School of Medicine
United States
Gerald W Dorn
Gerald W Dorn
Center for Pharmacogenomics
Palo Alto | United States

Circ Res 2011 Jan 28;108(1):18-26. Epub 2010 Oct 28.

Center for Pharmacogenomics, Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.

Rationale: MicroRNAs (miRs) are expanding our understanding of cardiac disease and have the potential to transform cardiovascular therapeutics. One miR can target hundreds of individual mRNAs, but existing methodologies are not sufficient to accurately and comprehensively identify these mRNA targets in vivo.

Objective: To develop methods permitting identification of in vivo miR targets in an unbiased manner, using massively parallel sequencing of mouse cardiac transcriptomes in combination with sequencing of mRNA associated with mouse cardiac RNA-induced silencing complexes (RISCs).

Methods And Results: We optimized techniques for expression profiling small amounts of RNA without introducing amplification bias and applied this to anti-Argonaute 2 immunoprecipitated RISCs (RISC-Seq) from mouse hearts. By comparing RNA-sequencing results of cardiac RISC and transcriptome from the same individual hearts, we defined 1645 mRNAs consistently targeted to mouse cardiac RISCs. We used this approach in hearts overexpressing miRs from Myh6 promoter-driven precursors (programmed RISC-Seq) to identify 209 in vivo targets of miR-133a and 81 in vivo targets of miR-499. Consistent with the fact that miR-133a and miR-499 have widely differing "seed" sequences and belong to different miR families, only 6 targets were common to miR-133a- and miR-499-programmed hearts.

Conclusions: RISC-sequencing is a highly sensitive method for general RISC profiling and individual miR target identification in biological context and is applicable to any tissue and any disease state.

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.110.233528DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017647PMC
January 2011
5 Reads

Publication Analysis

Top Keywords

mouse cardiac
12
identification vivo
8
mir target
8
vivo targets
8
targets
6
cardiac
5
small amounts
4
amounts rna
4
mir families
4
profiling small
4
techniques expression
4
expression profiling
4
families targets
4
rna introducing
4
introducing amplification
4
"seed" sequences
4
applied anti-argonaute
4
immunoprecipitated riscs
4
bias applied
4
amplification bias
4

Similar Publications

Cardiac Disease Status Dictates Functional mRNA Targeting Profiles of Individual MicroRNAs.

Circ Cardiovasc Genet 2015 Dec 9;8(6):774-84. Epub 2015 Nov 9.

From the Department of Internal Medicine, Center for Pharmacogenomics, Washington University School of Medicine, St. Louis, MO.

Background: MicroRNAs are key players in cardiac stress responses, but the mRNAs, whose abundance and translational potential are primarily affected by changes in cardiac microRNAs, are not well defined. Stimulus-induced, large-scale alterations in the cardiac transcriptome, together with consideration of the law of mass action, further suggest that the mRNAs most substantively targeted by individual microRNAs will vary between unstressed and stressed conditions. To test the hypothesis that microRNA target profiles differ in health and disease, we traced the fate of empirically determined miR-133a and miR-378 targets in mouse hearts undergoing pressure overload hypertrophy. Read More

View Article
December 2015

Genome-wide identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IP.

RNA Biol 2013 Jun 15;10(6):1018-29. Epub 2013 Apr 15.

German Cancer Research Center, Division of Molecular Genetics, Heidelberg, Germany.

MicroRNAs (miRNAs) are single-stranded, small, non-coding RNAs, which fine-tune protein expression by degrading and/or translationally inhibiting mRNAs. Manipulation of miRNA expression in animal models frequently results in severe phenotypes indicating their relevance in controlling cellular functions, most likely by interacting with multiple targets. To better understand the effect of miRNA activities, genome-wide analysis of their targets are required. Read More

View Article
June 2013

Regulation of cardiac microRNAs by cardiac microRNAs.

Circ Res 2013 Jun 26;113(1):62-71. Epub 2013 Apr 26.

Department of Internal Medicine, Center for Pharmacogenomics, Washington University School of Medicine, St. Louis, MO 63110, USA.

Rationale: MicroRNAs modestly suppress their direct mRNA targets, and these direct effects are amplified by modulation of gene transcription pathways. Consequently, indirect mRNA modulatory effects of microRNAs to increase or decrease mRNAs greatly outnumber direct target suppressions. Because microRNAs are products of transcription, the potential exists for microRNAs that regulate transcription to regulate other microRNAs. Read More

View Article
June 2013